Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Key paediatric messages from the 2018 European Respiratory Society International Congress.
Nenna R, Hunt KA, Dassios T, Collins JJP, Rottier RJ, Liu NM, Rottier B, Goutaki M, Karadag B, Prayle A, Fernandes RM, Parisi GF, Barben J, Rubbo B, Snijders D, Makrinioti H, Hall G, Pijnenburg MW, Grigg J. Nenna R, et al. ERJ Open Res. 2019 Apr 29;5(2):00241-2018. doi: 10.1183/23120541.00241-2018. eCollection 2019 Apr. ERJ Open Res. 2019. PMID: 31044141 Free PMC article.
Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
Tiberti C, Nenna R, Tromba V, Filardi T, Petrarca L, Silvestri F, Fassino V, Montuori M, Mancino E, Lenzi A, Midulla F, Costantino F, Morano S. Tiberti C, et al. Among authors: nenna r. Acta Diabetol. 2023 Oct;60(10):1309. doi: 10.1007/s00592-023-02152-6. Acta Diabetol. 2023. PMID: 37474814 Free PMC article. No abstract available.
No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
Tiberti C, Nenna R, Tromba V, Filardi T, Petrarca L, Silvestri F, Fassino V, Montuori M, Mancino E, Lenzi A, Midulla F, Costantino F, Morano S. Tiberti C, et al. Among authors: nenna r. Acta Diabetol. 2023 Oct;60(10):1301-1307. doi: 10.1007/s00592-023-02103-1. Epub 2023 May 12. Acta Diabetol. 2023. PMID: 37171699 Free PMC article.
Severe disease in Cystic Fibrosis and fecal calprotectin levels.
Parisi GF, Papale M, Rotolo N, Aloisio D, Tardino L, Scuderi MG, Di Benedetto V, Nenna R, Midulla F, Leonardi S. Parisi GF, et al. Among authors: nenna r. Immunobiology. 2017 Mar;222(3):582-586. doi: 10.1016/j.imbio.2016.11.005. Epub 2016 Nov 13. Immunobiology. 2017. PMID: 28012584
Novel therapies for severe asthma in children and adults.
Delimpoura V, Bostantzoglou C, Liu N, Nenna R. Delimpoura V, et al. Among authors: nenna r. Breathe (Sheff). 2018 Mar;14(1):59-62. doi: 10.1183/20734735.018917. Breathe (Sheff). 2018. PMID: 29515670 Free PMC article.
Key paediatric messages from the 2017 European Respiratory Society International Congress.
Grigg J, Barben J, Everard ML, Hall G, Karadag B, Moeller A, Nenna R, Priftis KN, Rottier RJ, Terheggen-Lagro SWJ, Midulla F. Grigg J, et al. Among authors: nenna r. ERJ Open Res. 2018 May 25;4(2):00165-2017. doi: 10.1183/23120541.00165-2017. eCollection 2018 Apr. ERJ Open Res. 2018. PMID: 29850468 Free PMC article. Review.
ERS statement on tracheomalacia and bronchomalacia in children.
Wallis C, Alexopoulou E, Antón-Pacheco JL, Bhatt JM, Bush A, Chang AB, Charatsi AM, Coleman C, Depiazzi J, Douros K, Eber E, Everard M, Kantar A, Masters IB, Midulla F, Nenna R, Roebuck D, Snijders D, Priftis K. Wallis C, et al. Among authors: nenna r. Eur Respir J. 2019 Sep 28;54(3):1900382. doi: 10.1183/13993003.00382-2019. Print 2019 Sep. Eur Respir J. 2019. PMID: 31320455 Free article.
171 results